Novartis under fire for accepting new reward for old drug.
Anderson
Tatum
T
D000962:Antimalarials; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins; D001363:Awards and Prizes; D017277:Drug Approval / Q000191:economics / Q000458:organization & administration*; D004338:Drug Combinations; D004345:Drug Industry / Q000191:economics / Q000941:ethics*; D004983:Ethanolamines; D005449:Fluorenes; D006801:Humans
D000962:Antimalarials; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins; D004338:Drug Combinations; D004983:Ethanolamines; D005449:Fluorenes